[61] demonstrated which the CRISPR/Cas9 process could specially concentrate on and cleave conserved regions during the HBV genome, producing strong suppression of viral gene expression and replication both of those in vitro As well as in vivoThey observed that Cas9-mediated base enhancing is a potential technique to get rid of CHB by completely ina